🇺🇸 FDA
Pipeline program

SUBLOCADE

HM20015109

Phase 3 small_molecule terminated

Quick answer

SUBLOCADE for Opioid Use Disorder is a Phase 3 program (small_molecule) at Indivior Pharmaceuticals with 2 ClinicalTrials.gov record(s).

Program details

Company
Indivior Pharmaceuticals
Indication
Opioid Use Disorder
Phase
Phase 3
Modality
small_molecule
Status
terminated

Clinical trials